GSK PLC header image

GSK PLC

GSK

Equity

ISIN null / Valor 120042705

New York Stock Exchange, Inc (2026-01-30)
USD 51.60+1.86%

GSK PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

GSK PLC is a global healthcare company specializing in pharmaceuticals and vaccines, dedicated to preventing and treating a wide range of diseases. The company operates through key therapeutic areas including respiratory, immunology and inflammation, oncology, as well as HIV and other infectious diseases. Notably, GSK majority-owns ViiV Healthcare, the sole company exclusively focused on HIV treatment and prevention, aiming to end the HIV epidemic. With a robust portfolio of over 20 marketed vaccines, GSK delivers more than one million vaccine doses daily, addressing infectious diseases across all age groups. The company's approach emphasizes early intervention and the use of advanced technologies to support healthcare systems and improve patient outcomes. GSK's commitment to responsible business practices underpins its strategy for long-term growth and trust-building with stakeholders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

45.9%1Y
46.9%3Y
10.8%5Y

Performance

28.3%1Y
63.5%3Y
51.5%5Y

Volatility

Market cap

103871 M

Market cap (USD)

Daily traded volume (Shares)

5,489,868

Daily traded volume (Shares)

1 day high/low

34.04 / 33.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.26%USD 119.38
Evotec SE
Evotec SE Evotec SE Valor: 3979578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.44%USD 3.65
Amicus Therapeutics Inc
Amicus Therapeutics Inc Amicus Therapeutics Inc Valor: 2644388
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.14%USD 14.29
Staar Surgical Co
Staar Surgical Co Staar Surgical Co Valor: 972813
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.05%USD 18.95
PTC Therapeutics Inc
PTC Therapeutics Inc PTC Therapeutics Inc Valor: 2515234
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%USD 75.53
Guardant Health Inc
Guardant Health Inc Guardant Health Inc Valor: 43633454
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.22%USD 114.04
National Vision Holdings Inc
National Vision Holdings Inc National Vision Holdings Inc Valor: 38523646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.72%USD 26.35
AbCellera Biologics Inc
AbCellera Biologics Inc AbCellera Biologics Inc Valor: 58489933
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.22%USD 3.62
PharmaSGP Holding SE
PharmaSGP Holding SE PharmaSGP Holding SE Valor: 55294050
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.13%EUR 33.00
MPH Health Care AG
MPH Health Care AG MPH Health Care AG Valor: 57233620
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.41%EUR 24.20